23 August 2023: Kadans Science Partner (“Kadans”) is set to welcome AviadoBio to its recently completed wet lab innovation and flexible workspace centre at 20 Water Street in Canary Wharf. AviadoBio, ...
Kadans Science Partner has added two further buildings at Abingdon Science Park, Oxfordshire, to its Pan-European science park portfolio. Monarch House and Penlon House have been acquired from two ...
Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression, following a recent £90m Series A financing 12 ...
Kadans Science Partner has acquired Oxford Biomedica’s Windrush Court in Oxford for £60m in a sale-and-leaseback transaction. The deal exceeds Oxford Biomedica’s target of £55m and the firm said the ...
This series goes deep with some of the most compelling figures in commercial real estate: the deal-makers, the game-changers, the city-shapers and the larger-than-life personalities who keep CRE ...
Leemhuis will move into the newly created role of executive chair management committee. The appointments are effective immediately. The two will work collaboratively with AXA IM Alts, with Ribbens ...
Kadans Science Partner, a leading investor in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors, today announced that construction work has started at ...
Dutch science park investor and developer Kadans has hired Cushman & Wakefield partner James Sheppard to head up and grow its UK and Ireland business. Kadans is backed by Oaktree Capital Management, ...
Canary Wharf Group’s chief executive has said the “evolution” of the area which is diversifying beyond offices is well underway, after securing the green-light to develop a major new 23-storey life ...
Construction of a multi-tenant building, Plus Ultra III, officially commenced yesterday at Wageningen University in the Netherlands. On completion, Australian technology manufacturer Flavourtech will ...
A thriving start-up ecosystem is essential to the health of the modern life sciences industry, as it provides an incubator for innovative ideas that might be too high-risk for larger, more ...